Filter your results
- 1
- 1
- 2
- 2
- 1
- 1
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Distinct expression of interleukin (IL)-36 α, β and γ , their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's diseaseClinical and Experimental Immunology, 2016, 184 (2), pp.159-173. ⟨10.1111/cei.12761⟩
Journal articles
hal-03153612v1
|
||
|
RhoA expression is controlled by nitric oxide through cGMP-dependent protein kinase activationJ Biol Chem, 2003, 278 (11), pp.9472-80. ⟨10.1074/jbc.M212776200⟩
Journal articles
hal-02363792v1
|